with C-terminal Human IgG Fc LQDPCSNCPAGTFCDNNRNQICSPCPPNSFSSAGGQRTCDICRQCKGVFRTRKECSSTSNAECDCTPGFHCLGAGCSMCEQDCKQGQELTKKGCKDCCFGTFNDQKRGICRPWTNCSLDGKSVLVNGTKERDVVCGPSPADLSPGASSVTPPAPAREPGHSPQAAAPKSSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
The elucidation of the structures of the AR DNA binding domain (DBD) and ligand binding domain (LBD) provides a new framework for understanding the functions of this receptor and leads to the development of rational drug design for the treatment of prostate cancer [PMID: 24909511]
IL-6 blockade was also evaluated for cancer treatment
add organoid passage culture buffer g to stop digestion
TNFR-2 directly promotes the proliferation of some kinds of tumor cells
Human IgG4 Recombinant Rabbit mAb (S-1140-53) Proteins and Enzymes with C-terminal Human IgG FcProduct Specification Host Rabbit Antigen Human IgG4 Synonyms Immunoglobulin heavy constant gamma 4, Ig gamma 4 chain C region, IGHG4 Immunogen Synthetic Peptide Location Secreted Accession P01861 Clone Number S 1140 53 Antibody Type Recombinant mAb Isotype IgG Application ELISA, WB, IHC P, IF Reactivity Hu Purification Protein A Concentration 0. 5 mg ml Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS, 40% Glycerol, 0. 05% BSA,